Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated:  6/28/2017
Clinical Research Facility
mi
from
East Windsor, NJ
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated: 6/28/2017
Clinical Research Facility
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated:  6/28/2017
Clinical Research Facility
mi
from
High Point, NC
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated: 6/28/2017
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated:  6/28/2017
Clinical Research Facility
mi
from
Raleigh, NC
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated: 6/28/2017
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated:  6/28/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated: 6/28/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated:  6/28/2017
Clinical Research Facility
mi
from
Nashville, TN
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceuticals Ltd) to the Marketed Product ELIDEL® (Pimecrolimus) Cream, 1% (Valeant Pharmaceuticals North America LLC) in the Treatment of Mild to Moderate Atopic Dermatitis (AD).
Status: Enrolling
Updated: 6/28/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Santa Monica, CA
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Indianapolis, IN
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Plainfield, IN
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Plainfield, IN
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Louisville, KY
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Portland, OR
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Johnston, RI
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Johnston, RI
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
San Antonio, TX
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
Clinical Research Facility
mi
from
Spokane, WA
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated:  7/6/2017
mi
from
Bydgoszcz,
A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled, Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
Status: Enrolling
Updated: 7/6/2017
mi
from
Bydgoszcz,
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Encino, CA
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Encino, CA
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Coral Gables, FL
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Hialeah, FL
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Hialeah, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Kissimmee, FL
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Miami, FL
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Miami, FL
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Pembroke Pines, FL
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Las Vegas, NV
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated:  7/18/2017
Cellceutix Study Center
mi
from
Huntsville, AL
Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis
A Randomized, Double Blind, Parallel Group, Placebo Controlled Clinical Study of the Efficacy and Safety of Three Different Daily Dosages of Prurisol Administered Orally to Subjects With Active Mild to Moderate Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/18/2017
Cellceutix Study Center
mi
from
Huntsville, AL
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Birmingham, AL
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Hot Springs, AR
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Rogers, AR
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Rogers, AR
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Bakersfield, CA
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Burbank, CA
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Irvine, CA
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Sacramento, CA
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Aurora, CO
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Aventura, FL
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Pembroke Pines, FL
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Alpharetta, GA
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Macon, GA
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Carmel, IN
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Carmel, IN
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Overland Park, KA
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Louisville, KY
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Owensboro, KY
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Owensboro, KY
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Silver Spring, MD
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Clarkston, MI
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Clarkston, MI
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
East Windsor, NJ
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
New York, NY
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Rochester, NY
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Gahanna, OH
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Gahanna, OH
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Warren, OH
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Warren, OH
Click here to add this to my saved trials
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated:  8/2/2017
Clinical Research Facility
mi
from
Portland, OR
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
A Prospective, Observational Study to Estimate the Proportion of Subjects With Plaque Psoriasis Who Achieve Complete Clearance on Biologics
Status: Enrolling
Updated: 8/2/2017
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials